DWS CROCI US Inst holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
DWS CROCI U.S. Fund - Class Inst DCUIX
- NAV / 1-Day Return 16.02 / −0.74 %
- Total Assets 745.5M
-
Adj. Expense Ratio
0.670%
- Expense Ratio 0.670%
- Distribution Fee Level Average
- Share Class Type Institutional
- Category Large Value
- Investment Style Mid Value
- Min. Initial Investment 1M
- Status Open
- TTM Yield 1.51%
- Turnover 76%
USD | NAV as of Jul 18, 2026 | 1-Day Return as of Jul 18, 2026, 2:15 AM GMT+0
Morningstar’s Analysis DCUIX
Will DCUIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 31.1
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Micron Technology Inc | 5.81 | 43M | Technology |
Alphabet Inc Class A | 3.55 | 27M | Communication Services |
The Kraft Heinz Co | 3.22 | 24M | Consumer Defensive |
Cognizant Technology Solutions Corp Class A | 3.20 | 24M | Technology |
Bristol-Myers Squibb Co | 3.10 | 23M | Healthcare |
Merck & Co Inc | 2.75 | 21M | Healthcare |
Pfizer Inc | 2.62 | 20M | Healthcare |
Synchrony Financial | 2.31 | 17M | Financial Services |
Dell Technologies Inc Ordinary Shares - Class C | 2.30 | 17M | Technology |
Devon Energy Corp | 2.26 | 17M | Energy |